Acupuncture Combined With Nimodipine for Prevention of Post-stroke

See also
Status	Clinical Trial	Phase
Completed	`NCT04588649` - The Aging Brain and Cognition: Contribution of Vascular Injury, Amyloid Plaque and Tau Protein to Cognitive Dysfunction After Stroke	Phase 2
Recruiting	`NCT05326724` - The Role of Acupuncture-induced Exosome in Treating Post-stroke Dementia	N/A
Completed	`NCT02585349` - Cognition and Affect After Stroke: a Prospective Evaluation of Risks

See also

Status

Clinical Trial

Phase

Completed

NCT04588649 - The Aging Brain and Cognition: Contribution of Vascular Injury, Amyloid Plaque and Tau Protein to Cognitive Dysfunction After Stroke

Phase 2

Recruiting

NCT05326724 - The Role of Acupuncture-induced Exosome in Treating Post-stroke Dementia

N/A

Completed

NCT02585349 - Cognition and Affect After Stroke: a Prospective Evaluation of Risks

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT06007573
Study type	Interventional
Source	The Second Affiliated Hospital of Anhui University of Traditional Chinese Medicine
Contact
Status	Completed
Phase	N/A
Start date	February 1, 2021
Completion date	August 15, 2023

Acupuncture Combined With Nimodipine for Prevention of Post-stroke Dementia

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms